HTG Molecular Diagnostics (HTGM) Short Interest Ratio & Short Volume → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Free HTGM Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis HTG Molecular Diagnostics Short Interest DataCurrent Short Volume2,700 sharesPrevious Short Volume58,400 sharesChange Vs. Previous Month-95.38%Dollar Volume Sold Short$5,751.00Short Interest Ratio / Days to Cover0.0Last Record DateMay 31, 2023Outstanding Shares2,210,000 sharesFloat Size2,120,000 sharesShort Percent of Float0.13%Today's Trading Volume773,040 sharesAverage Trading Volume294,806 sharesToday's Volume Vs. Average262% Short Selling HTG Molecular Diagnostics ? Sign up to receive the latest short interest report for HTG Molecular Diagnostics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHTGM Short Interest Over TimeHTGM Days to Cover Over TimeHTGM Percentage of Float Shorted Over Time Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story HTG Molecular Diagnostics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/31/20232,700 shares $5,751.00 -95.4%0.1%0 $2.13 5/15/202358,400 shares $153,008.00 +13.8%2.8%0.3 $2.62 4/30/202351,300 shares $126,711.00 -11.7%2.4%0.2 $2.47 4/15/202358,100 shares $173,138.00 -7.8%2.9%0.2 $2.98 3/31/202363,000 shares $170,100.00 +30.4%3.2%0.1 $2.70 3/15/202348,300 shares $149,730.00 -55.8%6.6%0 $3.10 Get the Latest News and Ratings for HTGM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for HTG Molecular Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 2/28/2023109,300 shares $392,387.00 +3.3%14.9%0.1 $3.59 2/15/2023105,800 shares $414,736.00 +167.2%14.4%0.1 $3.92 1/31/202339,600 shares $173,448.00 -23.7%5.4%0 $4.38 1/15/202351,900 shares $254,829.00 -51.0%7.1%0 $4.91 12/30/2022106,000 shares $422,940.00 -60.4%15.5%0.1 $3.99 12/15/2022267,700 shares $170,257.20 +660.5%N/A0.6 $0.64 11/30/202235,200 shares $11,616.00 -79.1%N/A0.3 $0.33 11/15/2022168,300 shares $95,931.00 -31.9%N/A1.6 $0.57 10/31/2022247,000 shares $130,910.00 -33.1%N/A1.6 $0.53 10/15/2022369,100 shares $213,339.80 +51.2%N/A1.3 $0.58 9/30/2022244,100 shares $149,633.30 +49.5%N/A0.3 $0.61 9/15/2022163,300 shares $140,438.00 +0.6%N/A0 $0.86 8/31/2022162,300 shares $140,064.90 +1.8%N/A0 $0.86 8/15/2022159,400 shares $168,964.00 -54.7%N/A0 $1.06 7/31/2022351,600 shares $365,664.00 -38.0%N/A0.1 $1.04 7/15/2022567,200 shares $1.07 million -79.5%N/A0.2 $1.89 6/30/20222,770,000 shares $2.85 million +1,987.4%N/A0.8 $1.03 6/15/2022132,700 shares $76,966.00 -13.8%N/A0.2 $0.58 5/31/2022153,900 shares $86,184.00 +170.5%N/A0.2 $0.56 5/15/202256,900 shares $34,822.80 -46.1%N/A0.1 $0.61 4/30/2022105,500 shares $93,821.15 -77.6%N/A0.2 $0.89 4/15/2022470,200 shares $512,518.00 +286.7%N/A0.9 $1.09 3/31/2022121,600 shares $169,024.00 +394.3%N/A0.3 $1.39 3/15/202224,600 shares $48,954.00 -1.2%N/A0.3 $1.99 2/28/202224,900 shares $48,306.00 -7.8%N/A0.4 $1.94 2/15/202227,000 shares $63,180.00 -28.0%N/A0.4 $2.34 1/31/202237,500 shares $107,625.00 -48.1%N/A0.6 $2.87 1/15/202272,200 shares $291,688.00 -38.1%N/A0 $4.04 12/31/2021116,700 shares $632,514.00 +28.1%N/A2.4 $5.42 12/15/202191,100 shares $354,379.00 +9.4%N/A2 $3.89 11/30/202183,300 shares $328,202.00 -30.2%N/A2.8 $3.94 11/15/2021119,300 shares $627,518.00 -10.8%N/A3.6 $5.26 10/29/2021133,700 shares $786,156.00 -12.2%N/A3.9 $5.88 10/15/2021152,200 shares $870,584.00 +20.8%N/A3.6 $5.72Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story HTGM Short Interest - Frequently Asked Questions What is HTG Molecular Diagnostics' current short interest? Short interest is the volume of HTG Molecular Diagnostics shares that have been sold short but have not yet been closed out or covered. As of May 31st, traders have sold 2,700 shares of HTGM short. 0.13% of HTG Molecular Diagnostics' shares are currently sold short. Learn More on HTG Molecular Diagnostics' current short interest. What is a good short interest percentage for HTG Molecular Diagnostics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.13% of HTG Molecular Diagnostics' floating shares are currently sold short. Is HTG Molecular Diagnostics' short interest increasing or decreasing? HTG Molecular Diagnostics saw a drop in short interest in the month of May. As of May 31st, there was short interest totaling 2,700 shares, a drop of 95.4% from the previous total of 58,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is HTG Molecular Diagnostics' float size? HTG Molecular Diagnostics currently has issued a total of 2,210,000 shares. Some of HTG Molecular Diagnostics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. HTG Molecular Diagnostics currently has a public float of 2,120,000 shares. How does HTG Molecular Diagnostics' short interest compare to its competitors? 0.13% of HTG Molecular Diagnostics' shares are currently sold short. Here is how the short interest of companies compare to HTG Molecular Diagnostics: American Oncology Network, Inc. (1.02%), Concord Medical Services Holdings Limited (0.06%), Context Therapeutics Inc. (0.08%), Guardant Health, Inc. (6.28%), Illumina, Inc. (3.32%), Agilent Technologies, Inc. (1.35%), and Thermo Fisher Scientific Inc. (0.68%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.00 billion), Suncor Energy Inc. ($2.98 billion), Charter Communications, Inc. ($2.88 billion), Occidental Petroleum Co. ($2.79 billion), Moderna, Inc. ($2.39 billion), Snowflake Inc. ($2.38 billion), Coinbase Global, Inc. ($2.22 billion), Palantir Technologies Inc. ($2.18 billion), T. Rowe Price Group, Inc. ($2.03 billion), and Verisk Analytics, Inc. ($2.02 billion). View all of the most shorted stocks. What does it mean to sell short HTG Molecular Diagnostics stock? Short selling HTGM is an investing strategy that aims to generate trading profit from HTG Molecular Diagnostics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against HTG Molecular Diagnostics? A short squeeze for HTG Molecular Diagnostics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HTGM, which in turn drives the price of the stock up even further. How often is HTG Molecular Diagnostics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HTGM, twice per month. The most recent reporting period available is May, 31 2023. More Short Interest Resources from MarketBeat Related Companies: ATNFW Short Interest ACONW Short Interest AIMDW Short Interest DRTSW Short Interest ALVOW Short Interest AONCW Short Interest AONC Short Interest APLMW Short Interest ARTLW Short Interest BIAFW Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:HTGM) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIBiden replacement revealed?Paradigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeThe #1 Crypto for 2024InvestorPlaceTop 5 AI Stocks to Buy for 2024Market Moving TrendsHow Biden has already won 2024Porter & Company